Shopping Cart 0
Cart Subtotal
USD 0

Xtant Medical Holdings Inc (XTNT) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company's products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Xtant Medical Holdings Inc, Medical Equipment, Deal Details 11

Partnerships 11

Xtant Medical Enters into Licensing Agreement with Sites Medical 11

X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12

Xtant Medical Enters into Distribution Agreement with Curasan 13

Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14

Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15

Xtant Medical Enters into Agreement with Montana State University 16

Equity Offering 17

Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17

Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18

Bacterin International Raises USD6.5 Million in Public Offering of Shares 20

Bacterin International Completes Private Placement Of Shares For USD 4 Million 22

Bacterin International Completes Private Placement Of Shares For USD 4.8 Million 23

Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24

Bacterin International Completes Private Placement Of Shares For USD 3.9 Million 25

Debt Offering 26

Xtant Medical Raises USD65 Million in Private Placement of Notes 26

Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27

Acquisition 28

Bacterin International Acquires X-spine Systems 28

Xtant Medical Holdings Inc-Key Competitors 29

Xtant Medical Holdings Inc-Key Employees 30

Xtant Medical Holdings Inc-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 32

Strategy And Business Planning 32

Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 32

Financial Announcements 33

Aug 07, 2018: Xtant Medical announces second quarter 2018 financial results 33

May 08, 2018: Xtant Medical Announces First Quarter 2018 Financial Results 35

Apr 02, 2018: Xtant Announces Fourth Quarter and Year End 2017 Financial Results 37

Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 40

Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 42

May 09, 2017: Xtant Medical Reports First Quarter Revenue of USD 22.1 million, 5% Growth Compared to the Prior Year Period 43

Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of USD 24.5 million, 10% Growth Compared to Prior Year Period 44

Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 46

Corporate Communications 47

Aug 20, 2018: Xtant Medical appoints Kathie Lenzen as Chief Financial Officer 47

Jul 10, 2018: Xtant Medical Names Kevin Brandt As Chief Commercial Officer 48

Feb 22, 2017: Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO 49

Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 50

Product News 51

Oct 25, 2017: Xtant Medical to Feature Product Portfolio at the 2017 North American Spine Society Annual Meeting 51

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Xtant Medical Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Xtant Medical Holdings Inc, Medical Equipment, Key Facts, 2017 2

Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Xtant Medical Holdings Inc, Deals By Market, 2012 to YTD 2018 9

Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Xtant Medical Enters into Licensing Agreement with Sites Medical 11

X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12

Xtant Medical Enters into Distribution Agreement with Curasan 13

Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14

Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15

Xtant Medical Enters into Agreement with Montana State University 16

Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17

Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18

Bacterin International Raises USD6.5 Million in Public Offering of Shares 20

Bacterin International Completes Private Placement Of Shares For USD 4 Million 22

Bacterin International Completes Private Placement Of Shares For USD 4.8 Million 23

Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24

Bacterin International Completes Private Placement Of Shares For USD 3.9 Million 25

Xtant Medical Raises USD65 Million in Private Placement of Notes 26

Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27

Bacterin International Acquires X-spine Systems 28

Xtant Medical Holdings Inc, Key Competitors 29

Xtant Medical Holdings Inc, Key Employees 30

Xtant Medical Holdings Inc, Subsidiaries 31

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Xtant Medical Holdings Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company's products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Xtant Medical Holdings Inc, Medical Equipment, Deal Details 11

Partnerships 11

Xtant Medical Enters into Licensing Agreement with Sites Medical 11

X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12

Xtant Medical Enters into Distribution Agreement with Curasan 13

Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14

Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15

Xtant Medical Enters into Agreement with Montana State University 16

Equity Offering 17

Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17

Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18

Bacterin International Raises USD6.5 Million in Public Offering of Shares 20

Bacterin International Completes Private Placement Of Shares For USD 4 Million 22

Bacterin International Completes Private Placement Of Shares For USD 4.8 Million 23

Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24

Bacterin International Completes Private Placement Of Shares For USD 3.9 Million 25

Debt Offering 26

Xtant Medical Raises USD65 Million in Private Placement of Notes 26

Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27

Acquisition 28

Bacterin International Acquires X-spine Systems 28

Xtant Medical Holdings Inc-Key Competitors 29

Xtant Medical Holdings Inc-Key Employees 30

Xtant Medical Holdings Inc-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 32

Strategy And Business Planning 32

Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 32

Financial Announcements 33

Aug 07, 2018: Xtant Medical announces second quarter 2018 financial results 33

May 08, 2018: Xtant Medical Announces First Quarter 2018 Financial Results 35

Apr 02, 2018: Xtant Announces Fourth Quarter and Year End 2017 Financial Results 37

Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 40

Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 42

May 09, 2017: Xtant Medical Reports First Quarter Revenue of USD 22.1 million, 5% Growth Compared to the Prior Year Period 43

Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of USD 24.5 million, 10% Growth Compared to Prior Year Period 44

Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 46

Corporate Communications 47

Aug 20, 2018: Xtant Medical appoints Kathie Lenzen as Chief Financial Officer 47

Jul 10, 2018: Xtant Medical Names Kevin Brandt As Chief Commercial Officer 48

Feb 22, 2017: Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO 49

Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 50

Product News 51

Oct 25, 2017: Xtant Medical to Feature Product Portfolio at the 2017 North American Spine Society Annual Meeting 51

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Xtant Medical Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Xtant Medical Holdings Inc, Medical Equipment, Key Facts, 2017 2

Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Xtant Medical Holdings Inc, Deals By Market, 2012 to YTD 2018 9

Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Xtant Medical Enters into Licensing Agreement with Sites Medical 11

X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12

Xtant Medical Enters into Distribution Agreement with Curasan 13

Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14

Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15

Xtant Medical Enters into Agreement with Montana State University 16

Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17

Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18

Bacterin International Raises USD6.5 Million in Public Offering of Shares 20

Bacterin International Completes Private Placement Of Shares For USD 4 Million 22

Bacterin International Completes Private Placement Of Shares For USD 4.8 Million 23

Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24

Bacterin International Completes Private Placement Of Shares For USD 3.9 Million 25

Xtant Medical Raises USD65 Million in Private Placement of Notes 26

Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27

Bacterin International Acquires X-spine Systems 28

Xtant Medical Holdings Inc, Key Competitors 29

Xtant Medical Holdings Inc, Key Employees 30

Xtant Medical Holdings Inc, Subsidiaries 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Xtant Medical Holdings Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.